Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
The Medical Journal of Australia|January 27, 2021
High prevalence of Crohn disease and ulcerative colitis among older people in SydneyAviv Pudipeddi, Jeffrey Liu, Viraj Kariyawasam, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 28, 2016
Family Impact and Infant Emotional Outcomes Following Diagnosis of Serious Liver Disease or Transplantation in InfancyMichael R Bowden, Looi C Ee, Usha Krishnan, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 4, 2020
Fecal Markers of Inflammation and Disease Activity in Pediatric Crohn Disease: Results from the ImageKids StudySteven T Leach, Andrew S Day, Rachel Messenger, et al.
Nutrients|January 8, 2025
Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern AnalysisDenelle Cosier, Kelly Lambert, Karen Charlton, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2026
Mosaic variants in KRAS and STAT5B associated with a mixed phenotype of two acquired errors of immunityJulia Forkgen, Etienne Masle-Farquhar, Yves Fontaine, et al.
Alimentary Pharmacology & Therapeutics|May 27, 2016
Review article: acute severe ulcerative colitis - evidence-based consensus statementsJ-H Chen, J M Andrews, V Kariyawasam, et al.
Gut|February 13, 2020
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practiceCraig Haifer, Colleen R Kelly, Sudarshan Paramsothy, et al.
The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.
Neurogastroenterology and Motility|May 22, 2018
Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstructionG Ravenscroft, S Pannell, G O'Grady, et al.
Pageof 14